Skip to NavigationSkip to content

Trump

How the US election could affect the pharmaceutical industry

Published on 04/11/20 at 01:18pm

The US is one of the most lucrative markets for the pharmaceutical industry. This is a country where a lack of strict price regulation can see companies make record profits, while also getting many of their research and development projects subsidised by the government. It is where Pfizer, Bristol Myers Squibb and Eli Lilly began their businesses, and all notable pharmaceutical companies have a major US presence.

The November 2020 issue of Pharmafocus is available to read free online now!

The latest monthly edition of Pharmafocus is available to read for free online now!

US could have avoided over 130,000 COVID-19 deaths, according to a new study

Photo by AgnosticPreachersKid

New studies suggest that the US could have avoided over 130,000 deaths if it responded earlier and in a coordinated manner to the coronavirus pandemic. 

34 reported coronavirus infections in White House-linked staff

Photo by AgnosticPreachersKid

The coronavirus outbreak that has infected notable figures of the Trump administration has spread to 34 White House Staffers and other contacts overall, according to an internal government memo. 

The memo was distributed among Federal Emergency Management Agency (FEMA) senior leadership on Wednesday and was obtained by ABC News

Regeneron applies for FDA Emergency Use Authorization for COVID-19 antibody treatment given to Trump

Photo by Michael Vadon (https://commons.wikimedia.org/wiki/File:President_of_the_United_States_Donald_J._Trump_at_CPAC_2017_February_24th_2017_by_Michael_Vadon_05.jpg)

Regeneron has announced that it has applied for an Emergency Use Authorization from the FDA for its experimental antibody therapy that has been given to President Trump in his fight against coronavirus. 

White House halts release of new FDA standards for the Emergency Use Authorization of COVID-19 vaccine

The Trump White House is blocking new federal guidance for the emergency release of coronavirus vaccines that would essentially ensure none would be approved before the presidential election. 

This follows months of debate between the FDA and Trump administration. Trump has insisted that a vaccine would start being rolled out before the general election on 3rd November. It is believed that private sector objections are another reason the guidelines are being blocked. 

Donald and Melania Trump test positive for COVID-19

Photo by Marc Nozell from Merrimack, New Hampshire, USA

President Donald Trump and First Lady Melania Trump have both tested positive for COVID-19. 

Trump tweeted: “Tonight, @FLOTUS and I tested positive for COVID-19. We will begin our quarantine and recovery process immediately. We will get through this TOGETHER!”

US won’t join COVAX coronavirus vaccine initiative because it is linked to the WHO

Photo by The White House

The US has said it will not participate in an international effort to develop and distribute a coronavirus vaccine.

COVAX is co-led by the World Health Organization, the Coalition for Epidemic Preparedness Innovations and Gavi.

It was announced last week that the initiative aims to work with vaccine manufacturers to provide equitable access to vaccines with 172 countries in discussions to participate. It aims to purchase two billion doses of a potential coronavirus vaccine by the end of 2021.  

Trump signs executive order to direct federal agencies to prioritise purchasing drugs made in the US

Official White House Photo by Tia Dufour

US President Donald Trump has signed an executive order which will direct federal agencies to prioritise buying drugs and drug ingredients that are made in the United States.

The order will also direct the FDA to produce a list of medicines that will be covered by the new requirements. Trump said during a speech in Ohio: “The executive order will require that US government agencies purchase all the essential medicines that we need from American sources.

Trump moves to formally remove the US from the World Health Organization

Photo by Gage Skidmore

President Donald Trump has formally moved to end the US membership of the World Health Organization.

He has notified both the UN and Congress of his intentions to withdraw on 6th July 2021. The Democrat controlled congress will probably not approve the move, but a 1948 resolution allows the US to withdraw if it gives a one year notice and pays all outstanding fees.

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches